Factors that influence treatment strategies in advanced colorectal cancer

European Journal of Surgical Oncology

Volumn 33, Issue SUPPL. 2, 2007, Pages

  Nesbitt, C ^a   Glendinning, R J ^a   Byrne, C ^a   Poston, G J ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

Chemotherapy associated steatohepatitis; Colorectal cancer; Liver metastases; Liver surgery; Neoadjuvent treatment; OncoSurge; Radiofrequency ablation; Staging

Indexed keywords

BEVACIZUMAB; CITUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINIC ACID; GADOLINIUM; IRINOTECAN; OXALIPLATIN; UNCLASSIFIED DRUG;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CATHETER ABLATION; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DECISION MAKING; HUMAN; LIVER METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW;

CATHETER ABLATION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DECISION MAKING, COMPUTER-ASSISTED; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PATIENT CARE TEAM; PATIENT SELECTION;

EID: 36749057427     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.09.019     Document Type: Review

References (47)

1. Poston G.J. Surgical strategies for colorectal liver metastases. Surg Oncol 13 (2004) 125-136
2. Stangl R., Altendorf-Hofmann A., Charnley R.M., and Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 343 (1994) 1405-1410
3. Geoghegan J.G., and Scheele J. Treatment of colorectal liver metastases. Br J Surg 86 (1999) 158-169
4. Sahani D.V., and Kalva S.P. Imaging the liver. Oncologist 9 (2004) 385-397
5. McLoughlin J.M., Jensen E.H., and Malafa M. Resection of colorectal liver metastases. Cancer Control 13 (2006) 32-41
6. Vauthey J.N. Patients with hepatic colorectal metastases. Program of the AHPBA 2006 consensus conference (January 25, 2006), California, San Francisco
7. Saini S. Imaging of hepatobiliary tract. N Engl J Med 336 (1997) 1889-1894
8. Charnsangavej C. Selection for resection: preoperative imaging evaluation. Program of the AHPBA 2006 consensus conference (January 25, 2006), California, San Francisco
9. Israel O., Mor M., Gaitini D., et al. Combined structural and functional evaluation of cancer patients with a hybrid camera based PET/CT system using (18) F-FDG. J Nucl Med 43 (2002) 1129-1136
10. Simmonds P.C., Primrose J.N., Colquitt J.L., Garden O.J., Poston G.J., and Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94 (2006) 982-999
11. Hughes K.S., Simon R., Songhorabodi S., et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 100 (1986) 278-284
12. Fong Y., Fortner J., Sun R.L., Brennan M.F., and Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309-318
13. Minagawa M., Makuuchi M., Torzilli G., et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231 (2000) 487-499
14. Vauthey J.N., Pawlik T.M., Abdalla E.K., et al. Is extended hepatectomy for hepatobiliary malignancy justified?. Ann Surg 239 (2004) 722-732
15. Scheele J., Stangl R., Altendorf-Hofmann A., and Paul M. Resection of colorectal liver metastases. World J Surg 19 (1995) 59-71
16. Pawlik T.M., Scoggins C.R., Zorzi D., et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241 (2005) 715-724
17. Adam R., Delvart V., Pascal G., et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240 (2004) 644-657
18. Petrowsky H., Gonen M., Jarnagin W., et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 235 (2002) 863-871
19. Kanemitsu Y., Kato T., Hirai T., and Yasui K. Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg 91 (2004) 112-120
20. Pozzo C., Basso M., Cassano A., et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 15 (2004) 933-939
21. Fong Y., and Bentrem D.J. CASH (Chemotherapy-Associated Steatohepatitis) costs. Ann Surg 243 (2006) 8-9
22. Poston G.J., and Byrne C. Decision making for patients with colorectal cancer liver metastases. Ann Surg Oncol 13 (2006) 10-11
23. Bilchik A.J., Poston G., Curley S.A., et al. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol 23 (2005) 9073-9078
24. Karoui M., Penna C., and Amin-Hashem M. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243 (2006) 1-7
25. Feliberti E.C., and Wagman L.D. Radiofrequency ablation of liver metastases from colorectal cancer. Cancer Control 13 (2006) 48-51
26. Primrose J.N. Treatment of colorectal metastases: surgery, cryotherapy or radiofrequency ablation. Gut 50 (2002) 1-5
27. Poston G.J. Radiofrequency ablation of colorectal liver metastases: where are we really going?. J Clin Oncol 23 (2005) 1342-1344
28. Mulier S., Mulier P., Ni Y., et al. Complications of radiofrequency coagulation of liver tumors. Br J Surg 89 (2002) 1206-1222
29. Curley S.A., Marra P., Beaty K.P.A.-C., et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 239 (2004) 450-458
30. AJCC. AJCC cancer staging manual. 6th ed. (2002), Springer Verlag, New York
31. Poston G.J., Adam R., and Vauthey J.-N. Comments and controversies: 'Downstaging' or 'downsizing': time for a new staging system in advanced colorectal cancer?. J Clin Oncol 24 (2006) 2702-2706
32. Van Cutsem E., Adam R., Rougier P., et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer 42 (2006) 2212-2221
33. Poston G.J., Adam R., Alberts S., et al. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol 23 (2005) 7125-7134
34. Martin R.C.G., Studts J.L., McGuffin S.A., et al. Method of presenting oncology treatment outcomes influences patient treatment decision-making in metastatic colorectal cancer. Ann Surg Oncol 13 (2006) 86-95
35. Faulkner A., and Maguire P. Talking to cancer patients and their relatives (1994), Oxford Medical Publications
36. Sanders T., and Skevington S. Participation as an expression of patient uncertainty: an exploration of bowel cancer consultations. Psycho-oncology 13 (2004) 675-688
37. Beaver K., Bogg J., and Luker K.A. Decision making role preferences and information needs: a comparison of colorectal and breast cancer. Health Expect 2 (1999) 266-276
38. Beaver K., Jones D., Susnerwala S., et al. Exploring decision making preferences of people with colorectal cancer. Health Expect 8 (2005) 103-113
39. Wright J.R., Whelan T.J., Schiff S., et al. Why cancer patients enter randomised clinical trials: exploring the factors that influence their decision. J Clin Oncol 22 43 (2004) 12-18
40. Dowsett S.M., Saul J.L., Butow P.N., et al. Communication style in the cancer consultation: preferences for a patient-centred approach. Psycho-oncology 9 (2000) 147-156
41. Coulter A. Paternalism or partnership? Patients have grown-up and there's no going back. BMJ 319 (1999) 719-720
42. Maguire P., Faulkner A., Booth K., et al. Helping cancer patients disclose their concerns. Eur J Cancer 32A (1996) 78-81
43. Heaven C.M., and Maguire P. Training hospice nurses to elicit patient concerns. J Adv Nurs 23 (1996) 280-286
44. Razavi D., Dlavaux N., Marchal S., De Cock M., Farvaques C., and Slachmuylder J.-L. Psycho-oncology 9 (2000) 293-302
45. Fallowfield L., Jenkins V., Farewell V., Saul J., Duffy A., and Eves R. Efficacy of a cancer research UK communication skills training model for oncologists: a randomised controlled trial. Lancet 359 (2002) 650-656
46. Booth K., Maguire P., Butterworth T., and Hillier V.F. Perceived professional support and the use of blocking behaviours by hospice nurses. J Adv Nurs 24 (1996) 522-527
47. Maguire P. Breaking bad news. Eur J Surg Oncol 24 (1998) 188-191